Cite
HARVARD Citation
Tzadok, R. et al. (n.d.). P442 Serum vedolizumab trough levels are associated with remission rate but not with extra-intestinal manifestations in IBD patients. Journal of Crohn's and colitis. pp. S441-S442. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tzadok, R. et al. (n.d.). P442 Serum vedolizumab trough levels are associated with remission rate but not with extra-intestinal manifestations in IBD patients. Journal of Crohn's and colitis. pp. S441-S442. [Online].